nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Blepharitis—Tretinoin—peripheral nervous system neoplasm	0.0242	0.0246	CcSEcCtD
Metipranolol—Blepharitis—Isotretinoin—peripheral nervous system neoplasm	0.0242	0.0246	CcSEcCtD
Metipranolol—Blepharitis—Alitretinoin—peripheral nervous system neoplasm	0.0183	0.0186	CcSEcCtD
Metipranolol—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.0162	0.0164	CcSEcCtD
Metipranolol—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.0162	0.0164	CcSEcCtD
Metipranolol—Photophobia—Tretinoin—peripheral nervous system neoplasm	0.014	0.0142	CcSEcCtD
Metipranolol—Photophobia—Isotretinoin—peripheral nervous system neoplasm	0.014	0.0142	CcSEcCtD
Metipranolol—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.0122	0.0124	CcSEcCtD
Metipranolol—Atrial fibrillation—Melphalan—peripheral nervous system neoplasm	0.0113	0.0114	CcSEcCtD
Metipranolol—Arthritis—Isotretinoin—peripheral nervous system neoplasm	0.0111	0.0113	CcSEcCtD
Metipranolol—Arthritis—Tretinoin—peripheral nervous system neoplasm	0.0111	0.0113	CcSEcCtD
Metipranolol—Photophobia—Alitretinoin—peripheral nervous system neoplasm	0.0106	0.0108	CcSEcCtD
Metipranolol—Arthritis—Alitretinoin—peripheral nervous system neoplasm	0.00842	0.00857	CcSEcCtD
Metipranolol—Lacrimation—Epirubicin—peripheral nervous system neoplasm	0.00839	0.00854	CcSEcCtD
Metipranolol—Acute coronary syndrome—Tretinoin—peripheral nervous system neoplasm	0.00821	0.00835	CcSEcCtD
Metipranolol—Acute coronary syndrome—Isotretinoin—peripheral nervous system neoplasm	0.00821	0.00835	CcSEcCtD
Metipranolol—Myocardial infarction—Tretinoin—peripheral nervous system neoplasm	0.00816	0.0083	CcSEcCtD
Metipranolol—Myocardial infarction—Isotretinoin—peripheral nervous system neoplasm	0.00816	0.0083	CcSEcCtD
Metipranolol—Conjunctivitis—Isotretinoin—peripheral nervous system neoplasm	0.00809	0.00823	CcSEcCtD
Metipranolol—Conjunctivitis—Tretinoin—peripheral nervous system neoplasm	0.00809	0.00823	CcSEcCtD
Metipranolol—Epistaxis—Topotecan—peripheral nervous system neoplasm	0.00792	0.00805	CcSEcCtD
Metipranolol—Epistaxis—Isotretinoin—peripheral nervous system neoplasm	0.00785	0.00799	CcSEcCtD
Metipranolol—Epistaxis—Tretinoin—peripheral nervous system neoplasm	0.00785	0.00799	CcSEcCtD
Metipranolol—Lacrimation—Doxorubicin—peripheral nervous system neoplasm	0.00777	0.0079	CcSEcCtD
Metipranolol—Rhinitis—Topotecan—peripheral nervous system neoplasm	0.00755	0.00768	CcSEcCtD
Metipranolol—Visual impairment—Isotretinoin—peripheral nervous system neoplasm	0.0072	0.00732	CcSEcCtD
Metipranolol—Visual impairment—Tretinoin—peripheral nervous system neoplasm	0.0072	0.00732	CcSEcCtD
Metipranolol—Tension—Tretinoin—peripheral nervous system neoplasm	0.00638	0.00649	CcSEcCtD
Metipranolol—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00638	0.00649	CcSEcCtD
Metipranolol—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00632	0.00643	CcSEcCtD
Metipranolol—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00632	0.00643	CcSEcCtD
Metipranolol—Acute coronary syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00622	0.00633	CcSEcCtD
Metipranolol—Myocardial infarction—Alitretinoin—peripheral nervous system neoplasm	0.00619	0.00629	CcSEcCtD
Metipranolol—Conjunctivitis—Alitretinoin—peripheral nervous system neoplasm	0.00613	0.00624	CcSEcCtD
Metipranolol—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00613	0.00624	CcSEcCtD
Metipranolol—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00613	0.00624	CcSEcCtD
Metipranolol—Acute coronary syndrome—Vincristine—peripheral nervous system neoplasm	0.00599	0.00609	CcSEcCtD
Metipranolol—Myocardial infarction—Vincristine—peripheral nervous system neoplasm	0.00596	0.00606	CcSEcCtD
Metipranolol—Epistaxis—Alitretinoin—peripheral nervous system neoplasm	0.00595	0.00605	CcSEcCtD
Metipranolol—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00575	0.00585	CcSEcCtD
Metipranolol—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00575	0.00585	CcSEcCtD
Metipranolol—Cough—Topotecan—peripheral nervous system neoplasm	0.00572	0.00582	CcSEcCtD
Metipranolol—Cough—Tretinoin—peripheral nervous system neoplasm	0.00568	0.00577	CcSEcCtD
Metipranolol—Cough—Isotretinoin—peripheral nervous system neoplasm	0.00568	0.00577	CcSEcCtD
Metipranolol—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00562	0.00571	CcSEcCtD
Metipranolol—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00562	0.00571	CcSEcCtD
Metipranolol—Cough—Melphalan—peripheral nervous system neoplasm	0.0056	0.0057	CcSEcCtD
Metipranolol—Myalgia—Topotecan—peripheral nervous system neoplasm	0.00558	0.00568	CcSEcCtD
Metipranolol—Myalgia—Tretinoin—peripheral nervous system neoplasm	0.00554	0.00563	CcSEcCtD
Metipranolol—Myalgia—Isotretinoin—peripheral nervous system neoplasm	0.00554	0.00563	CcSEcCtD
Metipranolol—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00552	0.00561	CcSEcCtD
Metipranolol—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00552	0.00561	CcSEcCtD
Metipranolol—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00552	0.00561	CcSEcCtD
Metipranolol—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00547	0.00557	CcSEcCtD
Metipranolol—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00547	0.00557	CcSEcCtD
Metipranolol—Myalgia—Melphalan—peripheral nervous system neoplasm	0.00547	0.00556	CcSEcCtD
Metipranolol—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.00546	0.00555	CcSEcCtD
Metipranolol—Atenolol—ABCB1—peripheral nervous system neoplasm	0.00536	0.323	CrCbGaD
Metipranolol—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.00536	0.00545	CcSEcCtD
Metipranolol—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00531	0.0054	CcSEcCtD
Metipranolol—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00531	0.0054	CcSEcCtD
Metipranolol—Acute coronary syndrome—Cisplatin—peripheral nervous system neoplasm	0.0053	0.00539	CcSEcCtD
Metipranolol—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.00527	0.00536	CcSEcCtD
Metipranolol—Oedema—Melphalan—peripheral nervous system neoplasm	0.00524	0.00533	CcSEcCtD
Metipranolol—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.00523	0.00531	CcSEcCtD
Metipranolol—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00496	0.00504	CcSEcCtD
Metipranolol—Acebutolol—ABCB1—peripheral nervous system neoplasm	0.00495	0.298	CrCbGaD
Metipranolol—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00491	0.005	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00488	0.00496	CcSEcCtD
Metipranolol—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.00486	0.00494	CcSEcCtD
Metipranolol—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00484	0.00492	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00484	0.00492	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00484	0.00492	CcSEcCtD
Metipranolol—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.00483	0.00491	CcSEcCtD
Metipranolol—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00479	0.00487	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00478	0.00486	CcSEcCtD
Metipranolol—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00477	0.00485	CcSEcCtD
Metipranolol—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00473	0.00481	CcSEcCtD
Metipranolol—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00473	0.00481	CcSEcCtD
Metipranolol—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00472	0.0048	CcSEcCtD
Metipranolol—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00472	0.0048	CcSEcCtD
Metipranolol—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00467	0.00475	CcSEcCtD
Metipranolol—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00465	0.00473	CcSEcCtD
Metipranolol—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00465	0.00473	CcSEcCtD
Metipranolol—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00453	0.0046	CcSEcCtD
Metipranolol—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00447	0.00455	CcSEcCtD
Metipranolol—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00436	0.00443	CcSEcCtD
Metipranolol—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00434	0.00441	CcSEcCtD
Metipranolol—Abnormal vision—Epirubicin—peripheral nervous system neoplasm	0.0043	0.00438	CcSEcCtD
Metipranolol—Cough—Alitretinoin—peripheral nervous system neoplasm	0.0043	0.00438	CcSEcCtD
Metipranolol—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00426	0.00433	CcSEcCtD
Metipranolol—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.0042	0.00427	CcSEcCtD
Metipranolol—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00418	0.00425	CcSEcCtD
Metipranolol—Metoprolol—ABCB1—peripheral nervous system neoplasm	0.00418	0.252	CrCbGaD
Metipranolol—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00415	0.00422	CcSEcCtD
Metipranolol—Hypertension—Vincristine—peripheral nervous system neoplasm	0.0041	0.00417	CcSEcCtD
Metipranolol—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00405	0.00411	CcSEcCtD
Metipranolol—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00402	0.00409	CcSEcCtD
Metipranolol—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.00398	0.00405	CcSEcCtD
Metipranolol—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00396	0.00403	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00395	0.00402	CcSEcCtD
Metipranolol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00394	0.00401	CcSEcCtD
Metipranolol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00391	0.00398	CcSEcCtD
Metipranolol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00391	0.00398	CcSEcCtD
Metipranolol—Oedema—Vincristine—peripheral nervous system neoplasm	0.00388	0.00394	CcSEcCtD
Metipranolol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00386	0.00393	CcSEcCtD
Metipranolol—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00384	0.00391	CcSEcCtD
Metipranolol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00381	0.00387	CcSEcCtD
Metipranolol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00381	0.00387	CcSEcCtD
Metipranolol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00376	0.00382	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00367	0.00373	CcSEcCtD
Metipranolol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00359	0.00365	CcSEcCtD
Metipranolol—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00358	0.00364	CcSEcCtD
Metipranolol—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00358	0.00364	CcSEcCtD
Metipranolol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00356	0.00362	CcSEcCtD
Metipranolol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00354	0.0036	CcSEcCtD
Metipranolol—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00353	0.00359	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00353	0.00359	CcSEcCtD
Metipranolol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00351	0.00357	CcSEcCtD
Metipranolol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00351	0.00357	CcSEcCtD
Metipranolol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00343	0.00349	CcSEcCtD
Metipranolol—Rash—Topotecan—peripheral nervous system neoplasm	0.00338	0.00343	CcSEcCtD
Metipranolol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00337	0.00343	CcSEcCtD
Metipranolol—Cough—Etoposide—peripheral nervous system neoplasm	0.00336	0.00342	CcSEcCtD
Metipranolol—Headache—Topotecan—peripheral nervous system neoplasm	0.00335	0.00341	CcSEcCtD
Metipranolol—Rash—Tretinoin—peripheral nervous system neoplasm	0.00335	0.0034	CcSEcCtD
Metipranolol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00335	0.0034	CcSEcCtD
Metipranolol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00335	0.0034	CcSEcCtD
Metipranolol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00335	0.0034	CcSEcCtD
Metipranolol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00333	0.00338	CcSEcCtD
Metipranolol—Headache—Tretinoin—peripheral nervous system neoplasm	0.00333	0.00338	CcSEcCtD
Metipranolol—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00332	0.00338	CcSEcCtD
Metipranolol—Rash—Melphalan—peripheral nervous system neoplasm	0.0033	0.00336	CcSEcCtD
Metipranolol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0033	0.00336	CcSEcCtD
Metipranolol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00324	0.00329	CcSEcCtD
Metipranolol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0032	0.00325	CcSEcCtD
Metipranolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.00318	0.00323	CcSEcCtD
Metipranolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00315	0.00321	CcSEcCtD
Metipranolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00315	0.00321	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00312	0.00318	CcSEcCtD
Metipranolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00311	0.00317	CcSEcCtD
Metipranolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00311	0.00317	CcSEcCtD
Metipranolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00306	0.00311	CcSEcCtD
Metipranolol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00302	0.00307	CcSEcCtD
Metipranolol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00298	0.00303	CcSEcCtD
Metipranolol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00297	0.00302	CcSEcCtD
Metipranolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00289	0.00294	CcSEcCtD
Metipranolol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00286	0.00291	CcSEcCtD
Metipranolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.0028	0.00285	CcSEcCtD
Metipranolol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00279	0.00284	CcSEcCtD
Metipranolol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00279	0.00284	CcSEcCtD
Metipranolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00278	0.00283	CcSEcCtD
Metipranolol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00276	0.0028	CcSEcCtD
Metipranolol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00274	0.00278	CcSEcCtD
Metipranolol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00268	0.00273	CcSEcCtD
Metipranolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00266	0.00271	CcSEcCtD
Metipranolol—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.0026	0.00265	CcSEcCtD
Metipranolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00258	0.00262	CcSEcCtD
Metipranolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00256	0.00261	CcSEcCtD
Metipranolol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00254	0.00258	CcSEcCtD
Metipranolol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00254	0.00258	CcSEcCtD
Metipranolol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00253	0.00257	CcSEcCtD
Metipranolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00252	0.00257	CcSEcCtD
Metipranolol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00252	0.00256	CcSEcCtD
Metipranolol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00248	0.00253	CcSEcCtD
Metipranolol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00248	0.00253	CcSEcCtD
Metipranolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00246	0.0025	CcSEcCtD
Metipranolol—Rash—Vincristine—peripheral nervous system neoplasm	0.00245	0.00249	CcSEcCtD
Metipranolol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00244	0.00248	CcSEcCtD
Metipranolol—Headache—Vincristine—peripheral nervous system neoplasm	0.00243	0.00247	CcSEcCtD
Metipranolol—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.00241	0.00245	CcSEcCtD
Metipranolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00243	CcSEcCtD
Metipranolol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00239	0.00243	CcSEcCtD
Metipranolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00233	0.00237	CcSEcCtD
Metipranolol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00231	0.00235	CcSEcCtD
Metipranolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.0023	0.00234	CcSEcCtD
Metipranolol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.0023	0.00234	CcSEcCtD
Metipranolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00225	0.00229	CcSEcCtD
Metipranolol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00221	0.00225	CcSEcCtD
Metipranolol—Rash—Cisplatin—peripheral nervous system neoplasm	0.00216	0.0022	CcSEcCtD
Metipranolol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00216	0.0022	CcSEcCtD
Metipranolol—Tension—Epirubicin—peripheral nervous system neoplasm	0.00212	0.00215	CcSEcCtD
Metipranolol—Propranolol—ABCB1—peripheral nervous system neoplasm	0.00211	0.127	CrCbGaD
Metipranolol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.0021	0.00213	CcSEcCtD
Metipranolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00208	0.00211	CcSEcCtD
Metipranolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00204	0.00207	CcSEcCtD
Metipranolol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00203	0.00207	CcSEcCtD
Metipranolol—Rash—Etoposide—peripheral nervous system neoplasm	0.00198	0.00201	CcSEcCtD
Metipranolol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00198	0.00201	CcSEcCtD
Metipranolol—Headache—Etoposide—peripheral nervous system neoplasm	0.00197	0.002	CcSEcCtD
Metipranolol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00196	0.00199	CcSEcCtD
Metipranolol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00194	0.00197	CcSEcCtD
Metipranolol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00191	0.00194	CcSEcCtD
Metipranolol—Cough—Epirubicin—peripheral nervous system neoplasm	0.00188	0.00191	CcSEcCtD
Metipranolol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00188	0.00191	CcSEcCtD
Metipranolol—Nausea—Etoposide—peripheral nervous system neoplasm	0.00187	0.0019	CcSEcCtD
Metipranolol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00186	0.00189	CcSEcCtD
Metipranolol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Metipranolol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00186	CcSEcCtD
Metipranolol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00181	0.00185	CcSEcCtD
Metipranolol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00179	CcSEcCtD
Metipranolol—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00176	0.00179	CcSEcCtD
Metipranolol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00177	CcSEcCtD
Metipranolol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.00175	CcSEcCtD
Metipranolol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.00173	CcSEcCtD
Metipranolol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00172	CcSEcCtD
Metipranolol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00171	CcSEcCtD
Metipranolol—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00163	0.00166	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.0016	0.00163	CcSEcCtD
Metipranolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00157	0.0016	CcSEcCtD
Metipranolol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00159	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00151	CcSEcCtD
Metipranolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00148	CcSEcCtD
Metipranolol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00147	CcSEcCtD
Metipranolol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.0013	0.00132	CcSEcCtD
Metipranolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00128	CcSEcCtD
Metipranolol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.00122	CcSEcCtD
Metipranolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00119	CcSEcCtD
Metipranolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00118	CcSEcCtD
Metipranolol—Rash—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00113	CcSEcCtD
Metipranolol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00111	0.00113	CcSEcCtD
Metipranolol—Headache—Epirubicin—peripheral nervous system neoplasm	0.0011	0.00112	CcSEcCtD
Metipranolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Metipranolol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00106	CcSEcCtD
Metipranolol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Metipranolol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Metipranolol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00104	CcSEcCtD
Metipranolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000968	0.000984	CcSEcCtD
